Veritable’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,927
Closed -$354K 915
2021
Q2
$354K Buy
1,927
+92
+5% +$16.9K 0.01% 629
2021
Q1
$281K Sell
1,835
-836
-31% -$128K ﹤0.01% 678
2020
Q4
$417K Sell
2,671
-878
-25% -$137K 0.01% 541
2020
Q3
$406K Sell
3,549
-263
-7% -$30.1K 0.01% 505
2020
Q2
$428K Buy
3,812
+240
+7% +$26.9K 0.01% 500
2020
Q1
$321K Sell
3,572
-1,065
-23% -$95.7K 0.01% 543
2019
Q4
$501K Sell
4,637
-518
-10% -$56K 0.01% 526
2019
Q3
$505K Sell
5,155
-9
-0.2% -$882 0.01% 508
2019
Q2
$676K Buy
5,164
+712
+16% +$93.2K 0.01% 431
2019
Q1
$602K Buy
4,452
+181
+4% +$24.5K 0.01% 454
2018
Q4
$416K Sell
4,271
-1,094
-20% -$107K 0.01% 503
2018
Q3
$746K Sell
5,365
-124
-2% -$17.2K 0.02% 401
2018
Q2
$681K Buy
5,489
+951
+21% +$118K 0.01% 426
2018
Q1
$506K Buy
4,538
+1,170
+35% +$130K 0.01% 491
2017
Q4
$403K Sell
3,368
-1,030
-23% -$123K 0.01% 552
2017
Q3
$617K Buy
4,398
+555
+14% +$77.9K 0.01% 454
2017
Q2
$468K Sell
3,843
-1,762
-31% -$215K 0.01% 523
2017
Q1
$680K Buy
5,605
+462
+9% +$56.1K 0.02% 414
2016
Q4
$629K Buy
5,143
+796
+18% +$97.4K 0.02% 413
2016
Q3
$533K Buy
4,347
+202
+5% +$24.8K 0.01% 447
2016
Q2
$484K Sell
4,145
-242
-6% -$28.3K 0.01% 460
2016
Q1
$611K Sell
4,387
-204
-4% -$28.4K 0.02% 390
2015
Q4
$876K Buy
4,591
+835
+22% +$159K 0.02% 341
2015
Q3
$587K Buy
3,756
+256
+7% +$40K 0.02% 403
2015
Q2
$633K Sell
3,500
-25,938
-88% -$4.69M 0.02% 405
2015
Q1
$5.1M Buy
29,438
+27
+0.1% +$4.68K 0.11% 146
2014
Q4
$5.44M Sell
29,411
-633
-2% -$117K 0.11% 145
2014
Q3
$4.98M Buy
30,044
+19,391
+182% +$3.22M 0.11% 143
2014
Q2
$1.67M Buy
10,653
+181
+2% +$28.3K 0.03% 288
2014
Q1
$1.59M Sell
10,472
-1,626
-13% -$247K 0.03% 290
2013
Q4
$1.61M Buy
12,098
+253
+2% +$33.6K 0.04% 283
2013
Q3
$1.38M Buy
11,845
+2,115
+22% +$246K 0.03% 312
2013
Q2
$897K Buy
+9,730
New +$897K 0.02% 421